Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement.
Publisher DOI
PubMed ID
33733675
Abstract
BACKGROUND
Procedural improvements combined with the contemporary clinical profile of patients undergoing transcatheter aortic valve replacement (TAVR) may have influenced the incidence and outcomes of infective endocarditis (IE) following TAVR. We aimed to determine the temporal trends, characteristics, and outcomes of IE post-TAVR.
METHODS
Observational study including 552 patients presenting definite IE post-TAVR. Patients were divided in 2 groups according to the timing of TAVR (historical cohort [HC]: before 2014; contemporary cohort [CC]: after 2014).
RESULTS
Overall incidence rates of IE were similar in both cohorts (CC vs HC: 5.45 vs 6.52 per 1000 person-years; P = .12), but the rate of early IE was lower in the CC (2.29‰ vs 4.89‰, P < .001). Enterococci were the most frequent microorganism. Most patients presented complicated IE ( CC: 67.7%; HC: 69.6%; P = .66), but the rate of surgical treatment remained low (CC: 20.7%; HC: 17.3%; P = .32). The CC exhibited lower rates of in-hospital acute kidney injury (35.1% vs 44.6%; P = .036) and in-hospital (26.6% vs 36.4%; P = .016) and 1-year (37.8% vs 53.5%; P < .001) mortality. Higher logistic EuroScore, Staphylococcus aureus etiology, and complications (stroke, heart failure, and acute renal failure) were associated with in-hospital mortality in multivariable analyses (P < .05 for all).
CONCLUSIONS
Although overall IE incidence has remained stable, the incidence of early IE has declined in recent years. The microorganism, high rate of complications, and very low rate of surgical treatment remained similar. In-hospital and 1-year mortality rates were high but progressively decreased over time.
Procedural improvements combined with the contemporary clinical profile of patients undergoing transcatheter aortic valve replacement (TAVR) may have influenced the incidence and outcomes of infective endocarditis (IE) following TAVR. We aimed to determine the temporal trends, characteristics, and outcomes of IE post-TAVR.
METHODS
Observational study including 552 patients presenting definite IE post-TAVR. Patients were divided in 2 groups according to the timing of TAVR (historical cohort [HC]: before 2014; contemporary cohort [CC]: after 2014).
RESULTS
Overall incidence rates of IE were similar in both cohorts (CC vs HC: 5.45 vs 6.52 per 1000 person-years; P = .12), but the rate of early IE was lower in the CC (2.29‰ vs 4.89‰, P < .001). Enterococci were the most frequent microorganism. Most patients presented complicated IE ( CC: 67.7%; HC: 69.6%; P = .66), but the rate of surgical treatment remained low (CC: 20.7%; HC: 17.3%; P = .32). The CC exhibited lower rates of in-hospital acute kidney injury (35.1% vs 44.6%; P = .036) and in-hospital (26.6% vs 36.4%; P = .016) and 1-year (37.8% vs 53.5%; P < .001) mortality. Higher logistic EuroScore, Staphylococcus aureus etiology, and complications (stroke, heart failure, and acute renal failure) were associated with in-hospital mortality in multivariable analyses (P < .05 for all).
CONCLUSIONS
Although overall IE incidence has remained stable, the incidence of early IE has declined in recent years. The microorganism, high rate of complications, and very low rate of surgical treatment remained similar. In-hospital and 1-year mortality rates were high but progressively decreased over time.
Date Issued
2021-12-06
Publication Type
Article
Subject(s)
Subjects
TAVR infective endocarditis prosthetic valve endocarditis transcatheter aortic valve replacement
Language(s)
en
Author(s)
Del Val, David | |
Abdel-Wahab, Mohamed | |
Linke, Axel | |
Durand, Eric | |
Ihlemann, Nikolaj | |
Urena, Marina | |
Pellegrini, Costanza | |
Giannini, Francesco | |
Landt, Martin | |
Auffret, Vincent | |
Sinning, Jan Malte | |
Cheema, Asim | |
Nombela-Franco, Luis | |
Chamandi, Chekrallah | |
Campelo-Parada, Francisco | |
Munoz-Garcia, Antonio | |
Herrmann, Howard C | |
Testa, Luca | |
Won-Keun, Kim | |
Castillo, Juan Carlos | |
Alperi, Alberto | |
Tchetche, Didier | |
Bartorelli, Antonio | |
Kapadia, Samir | |
Amat-Santos, Ignacio | |
Wijeysundera, Harindra C | |
Lisko, John | |
Gutiérrez-Ibanes, Enrique | |
Serra, Vicenç | |
Salido, Luisa | |
Alkhodair, Abdullah | |
Livi, Ugolino | |
Chakravarty, Tarun | |
Lerakis, Stamatios | |
Vilalta, Victoria | |
Regueiro, Ander | |
Romaguera, Rafael | |
Barbanti, Marco | |
Masson, Jean-Bernard | |
Maes, Frédéric | |
Fiorina, Claudia | |
Miceli, Antonio | |
Kodali, Susheel | |
Ribeiro, Henrique B | |
Mangione, Jose Armando | |
de Brito, Fabio Sandoli | |
Actis Dato, Guglielmo Mario | |
Rosato, Francesco | |
Ferreira, Maria-Cristina | |
Lima, Valter Correa | |
Colafranceschi, Alexandre Siciliano | |
Abizaid, Alexandre | |
Marino, Marcos Antonio | |
Esteves, Vinicius | |
Andrea, Julio | |
Godinho, Roger R | |
Eltchaninoff, Helene | |
Søndergaard, Lars | |
Himbert, Dominique | |
Husser, Oliver | |
Latib, Azeem | |
Le Breton, Hervé | |
Servoz, Clement | |
Pascual, Isaac | |
Siddiqui, Saif | |
Olivares, Paolo | |
Hernandez-Antolin, Rosana | |
Webb, John G | |
Sponga, Sandro | |
Makkar, Raj | |
Kini, Annapoorna S | |
Boukhris, Marouane | |
Mangner, Norman | |
Crusius, Lisa | |
Holzhey, David | |
Rodés-Cabau, Josep |
Additional Credits
Journal
Clinical infectious diseases
Publisher
Oxford University Press
ISSN
1537-6591
Access(Rights)
restricted